News
Role of TET2 in hematologic malignancies
New research appears to explain how TET2 mutations increase the risk of hematologic malignancies. In studying mouse models and patient samples,...
News
Drug receives fast track designation for follicular lymphoma
The US Food and Drug Administration (FDA) has granted fast track designation to the EZH2 inhibitor tazemetostat as a treatment for relapsed or...
News
Treatment granted PRIME designation for hemophilia B
The European Medicines Agency (EMA) has granted AMT-060 access to the agency’s PRIority MEdicines (PRIME) program. AMT-060 is an investigational...
News
FDA issues warnings about illegal ‘anticancer’ products
The US Food and Drug Administration (FDA) has posted warning letters addressed to 14 US-based companies illegally selling more than 65 products....
News
WES misses genes associated with leukemia, other diseases
Whole-exome sequencing (WES) may routinely miss genetic variations associated with leukemia and other diseases, according to research published in...
News
Study reveals ‘substantial’ malaria burden in US
Malaria imposes a substantial disease burden in the US, according to researchers. Their study indicates that malaria hospitalizations and deaths...
News
A spouse’s cancer diagnosis can lower household income
A spouse’s cancer diagnosis can significantly diminish family income, according to research published in the Journal of Health Economics....
News
Price transparency doesn’t impact ordering of lab tests
Seeing the cost of lab tests in patients’ health records doesn’t deter doctors from ordering the tests, according to research published in JAMA...
News
CHMP recommends inotuzumab ozogamicin for adult ALL
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion of inotuzumab ozogamicin (...
News
CHMP recommends approval for rituximab biosimilar
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for a biosimilar...
News
ALL, HL guidelines added to radiation therapy resource
The National Comprehensive Cancer Network® (NCCN) has added 9 disease sites to its NCCN Radiation Therapy Compendium™, a resource that provides a...
News
Second cancers take greater toll on younger patients
Second cancers take a greater toll on patients under the age of 40, according to research published in JAMA Oncology. Researchers studied 14...
News
Cord blood product bests standard UCB transplant
The expanded umbilical cord blood (UCB) product NiCord can provide benefits over standard UCB transplant, according to research published in...
News
TGA approves therapy for hemophilia A
The Australian Therapeutic Goods Administration (TGA) has approved use of lonoctocog alfa (AFSTYLA®), a recombinant single-chain coagulation...
News
How malaria parasites weaken RBCs’ defenses
Malaria parasites change the properties of red blood cells (RBCs) in a way that helps the parasites achieve cell entry, according to research...